These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9871599)

  • 1. Synthesis of 2,3,4a,11b-tetrahydro-oxazino[2,3-c]benzopyran-9-carbonitriles as ATP-sensitive potassium channel openers.
    Cheng CY; Chiu HI; Chang MJ; Lin YC; Tsai MC; Yu HC
    Bioorg Med Chem Lett; 1998 Mar; 8(5):463-8. PubMed ID: 9871599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acyl-1,2,3,4a,5,10b-hexahydro-[1]benzopyrano-[3,4-b][1,4]oxazine-9-carbonitriles as bladder-selective potassium channel openers.
    Chiu I; Lin YC; Cheng CY; Tsai MC; Yu HC
    Bioorg Med Chem; 2001 Feb; 9(2):383-93. PubMed ID: 11249131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
    Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ
    J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
    Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
    J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G; Henshaw M; Miller M; Weston AH
    Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder.
    Bonev AD; Nelson MT
    Am J Physiol; 1993 May; 264(5 Pt 1):C1190-200. PubMed ID: 8498480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical effect of minoxidil sulphate on guinea pig airways.
    Buchheit KH; Hofmann A; Manley P; Pfannkuche HJ; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):418-24. PubMed ID: 10763857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Arylated pyrrolidin-2-ones and morpholin-3-ones as potassium channel openers.
    Liang PH; Hsin LW; Cheng CY
    Bioorg Med Chem; 2002 Oct; 10(10):3267-76. PubMed ID: 12150872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the novel dihydropyridine potassium channel opener, (9R)-9-(3-iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the regulation of cardiovascular function in conscious and anesthetized beagle dogs.
    Fryer RM; Rakestraw PA; Preusser LC; Brune ME; Carroll WA; Buckner SA; Shieh CC; King LL; Marsh KC; Gopalakrishnan M; Cox BF; Reinhart GA
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):232-40. PubMed ID: 16044036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
    Atwal KS; Ferrara FN; Ding CZ; Grover GJ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
    J Med Chem; 1996 Jan; 39(1):304-13. PubMed ID: 8568821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization.
    Brune ME; Fey TA; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ; Gopalakrishnan M
    J Pharmacol Exp Ther; 2002 Oct; 303(1):387-94. PubMed ID: 12235275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of BRL55834 in rat portal vein and bovine trachea: evidence for the induction of a glibenclamide-resistant, ATP-sensitive potassium current.
    Edwards G; Schneider J; Niederste-Hollenberg A; Noack T; Weston AH
    Br J Pharmacol; 1995 Jul; 115(6):1027-37. PubMed ID: 7582499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ATP-sensitive K+ channels by ATP and nucleotide diphosphate in rabbit portal vein.
    Kamouchi M; Kitamura K
    Am J Physiol; 1994 May; 266(5 Pt 2):H1687-98. PubMed ID: 8203568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones.
    Gilbert AM; Antane MM; Argentieri TM; Butera JA; Francisco GD; Freeden C; Gundersen EG; Graceffa RF; Herbst D; Hirth BH; Lennox JR; McFarlane G; Norton NW; Quagliato D; Sheldon JH; Warga D; Wojdan A; Woods M
    J Med Chem; 2000 Mar; 43(6):1203-14. PubMed ID: 10737753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
    Atwal KS; Grover GJ; Ferrara FN; Ahmed SZ; Sleph PG; Dzwonczyk S; Normandin DE
    J Med Chem; 1995 May; 38(11):1966-73. PubMed ID: 7783128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levcromakalim may induce a voltage-independent K-current in rat portal veins by modifying the gating properties of the delayed rectifier.
    Edwards G; Ibbotson T; Weston AH
    Br J Pharmacol; 1993 Nov; 110(3):1037-48. PubMed ID: 8298792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zeneca ZD6169 and its analogs from a novel series of anilide tertiary carbinols: in vitro KATP channel opening activity in bladder detrusor.
    Li JH; Yasay GD; Zografos P; Kau ST; Ohnmacht CJ; Russell K; Empfield JR; Brown FJ; Trainor DA; Bonev AD
    Pharmacology; 1995 Jun; 51(1):33-42. PubMed ID: 7568342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.
    Wojdan A; Freeden C; Woods M; Oshiro G; Spinelli W; Colatsky TJ; Sheldon JH; Norton NW; Warga D; Antane MM; Antane SA; Butera JA; Argentieri TM
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1410-8. PubMed ID: 10336534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a novel ATP-sensitive potassium channel opener: hemodynamic comparison to ZD-6169, WAY-133537, and nifedipine in the anesthetized canine.
    Fryer RM; Preusser LC; Calzadilla SV; Hu Y; Xu H; Marsh KC; Cox BF; Lin CT; Gopalakrishnan M; Reinhart GA
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):137-47. PubMed ID: 15243293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.